This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
The role of drug metabolism enzymes as biomarkers of disease susceptibility in ALS.
Photo by JOSHUA COLEMAN on Unsplash
The first report of a defect in drug metabolism in subjects with ALS.
This page is a summary of: XENOBIOTIC METABOLISM IN MOTORNEURON DISEASE, The Lancet, September 1988, Elsevier,
DOI: 10.1016/s0140-6736(88)90467-9.
You can read the full text:
Be the first to contribute to this page
Journal of Speech Language and Hearing Research
Cochlear implant users have much difficulty with hearing different tones of timbres (spectral dimension), less with hearing different loudnesses (loudness dimension) and even less with time differe...
Journal of Clinical Nursing
An exploratory study of the smoking-related health beliefs of older people with chronic obstructive pulmonary disease
Frontiers in Genetics
CRISPR-Cas gene editing is a new technology being used to fight malnutrition through biofortification of food crops. It is seen as a solution due to its targeted gene editing, low cost, high effici...
